John Shearer Lambert

John Shearer Lambert est un médecin écossais exerçant actuellement à Dublin, en Irlande du sud.

Sur PubMed, il est John S Lambert, mais il se fait aussi appeler John (Jack) Lambert et Jack (John) Lambert ou tout simplement John Lambert ou Jack Lambert. Il intervient sur la Borréliose de Lyme à la fois en Ecosse, au Royaume-Uni et en Irlande depuis au moins 2016, promouvant les thèses et recommandations de l'ILADS.

Biographie de John Lambert sur le site du Mater Hospital de Dublin

[Traduction DeepL: ]
Le Dr John Lambert est consultant en maladies infectieuses et en médecine génito-urinaire. Il exerce à Dublin, en Irlande, en tant que consultant à l'hôpital universitaire Mater Misericordiae et à la maternité Rotunda, et enseigne à l'école de médecine et de sciences médicales de l'UCD [University College Dublin]. Il est directeur de l'unité nationale d'isolement pour les maladies hautement infectieuses à l'hôpital universitaire Mater Misericordiae et membre du comité national de la fièvre hémorragique virale du HSE. Il a également été impliqué dans le groupe de stratégie de santé sexuelle en Irlande et a enseigné aux médecins généralistes irlandais sur le sujet des MST [Maladies Sexuelles Transmissibles]. Il a été formé aux États-Unis, à l'Université d'État du Michigan et à Rochester NY, et a été professeur adjoint à l'Institut de virologie humaine de Johns Hopkins et de l'Université du Maryland à Baltimore avant de retourner au Royaume-Uni en 2000, où il a travaillé au St Mary's and Kings College Hospital de 2000 à 2005 avant sa nomination à Dublin. Ses travaux sur le VIH se sont concentrés sur l'étude des médicaments anti-VIH et sur la coinfection par le VIH et l'hépatite C. Il s'est également intéressé à l'infection par le VIH pendant la grossesse et aux études sur la surveillance des médicaments thérapeutiques pendant la grossesse. Il a rédigé plus de 10 chapitres de livres et 80 articles évalués par des pairs, principalement sur les maladies infectieuses, les vaccins, le VIH et les MST [Maladies sexuelles transmissibles].

Implication de John S. Lambert dans la demande de révision des codes CIM pour la Borreliose de Lyme à l'ONU et à l'OMS

Jenna Luché-Thayer, directrice du comité ad hoc, a donné un aperçu du rapport 2018 « La situation des défenseurs des droits humains de Lyme et des patients atteints de borréliose de la fièvre récurrente », qui a été suivi par des représentants partageant des cas de leurs pays. [...] Le professeur français Christian Perronne est un spécialiste des maladies infectieuses et tropicales de renommée internationale avec plus de 300 publications scientifiques et a joué un rôle consultatif auprès de l'OMS. Perronne a expliqué au Rapporteur spécial comment, à la suite de sa présentation de 2016 sur la LB à l'Académie nationale de médecine de France, il a été publiquement qualifié de « terroriste » par l'ancien président de l'Académie, le professeur Marc Gentilini. [...]

John Lambert apporte sa pierre à l'édifice, il écrit le 24 juin 2020 une lettre intitulée Time to recognise Congenital Lyme: an open letter to the WHO. On lit dans sa lettre (ou plus exactement leur lettre, puisque la lettre est signée à la fois par Christian Perronne et par John S Lambert) publiée par le Lyme Resource Centre (LRC) écossais [traduction google]:

Cher Dr Tedros Ghebreyesus,

Nous vous écrivons aujourd'hui pour protester contre la suppression du code 1C1G.2, pour la « borréliose congénitale de Lyme », des nouveaux codes CIM-11, et pour vous demander de soutenir son rétablissement en tant que catégorie « autonome ».

Avec la lettre actuelle (les communications précédentes sont restées sans réponse), nous espérons une fois de plus vous sensibiliser aux préoccupations importantes concernant la maladie de Lyme congénitale, et demandons à l'OMS d'embrasser la science, plutôt que de l'ignorer comme cela a été fait dans la CIM- 11 en ce qui concerne l'infection congénitale de Lyme à ce jour.

Une demande d'inscription de la « borréliose congénitale de Lyme » en tant que catégorie « autonome » dans les nouveaux codes de la CIM-11 a été faite par le Comité ad hoc pour l'équité en santé dans les codes de la borréliose de la CIM-11, soumise le 27 mars 2017 par Jenna Luché -Thayer et autres auteurs. À la suite d'un examen scientifique dirigé par l'OMS, le code 1C1G.2, pour « Borréliose congénitale de Lyme », a été publié dans le cadre de l'annonce de l'OMS de juin 2018 sur les « codes stables », ce qui signifie qu'ils ont été soigneusement vérifiés et acceptés comme stables.

Après son acceptation en juin 2018, le Comité consultatif médical et scientifique (MSAC) de l'OMS a apparemment procédé à un deuxième examen de ce « code stable » et a recommandé la suppression du code lors d'une réunion en octobre 2018 (1). Le comité ad hoc dirigé par Jenna Luché-Thayer n'a pas été informé de la réunion ou de la suppression du code. Ce n'est que par hasard que la suppression a été découverte sur le site Web de l'OMS. Aucune raison n'a été fournie lorsque les membres du comité ad hoc ont enquêté sur cette suppression secrète et inexplicable. Cependant, la correspondance d'un membre du comité de l'OMS indiquait que « c'était en réponse à une demande d'élimination de la borréliose congénitale de Lyme par l'Agence de la santé publique du Canada (ASPC)… ».

À la suite de la suppression de la « borréliose congénitale de Lyme » des codes CIM-11, entre juillet et octobre 2019, plusieurs communications demandant des éclaircissements ont été faites par le Dr John Lambert, des membres du comité ad hoc, des citoyens concernés, des députés, des membres de la Chambre des Lords du Royaume-Uni et les députés européens du monde entier aux personnes « responsables » au sein de l'OMS qui administrent les codes ICD-11. Il n'y a pas eu d'explication satisfaisante pour la suppression de la « borréliose congénitale de Lyme ». Une communication a déclaré que puisque la maladie de Lyme congénitale n'a pas de « syndrome congénital », elle n'a pas besoin d'un code autonome. Cependant, le paludisme congénital n'a pas de « syndrome congénital », mais il a un code autonome.

Le site Web des Centers for Disease Control and Prevention a été mis à jour le 27 janvier 2020 pour inclure la mère au fœtus comme moyen possible de transmission de la maladie. Le site indique maintenant :
la maladie de Lyme acquise pendant la grossesse peut entraîner une infection du placenta et une mortinaissance possible » et « La propagation de la mère au fœtus est possible mais rare ».

Alors que la «politique» de Lyme suit son cours, contrôlée non par la science mais par l'influence et l'intrigue, les enfants touchés et infectés par ces infections transmises par les tiques continuent de souffrir.

Nous demandons à l'OMS d'examiner le processus qui s'est déroulé entre octobre 2018 et mai 2020, et de fournir au comité ad hoc les noms des membres du comité de l'OMS, ainsi que les noms des correspondants et des copies de toute correspondance avec NICE et l'ASPC dont les actions ont initié une telle action secrète. Nous demandons en outre des copies du procès-verbal de la réunion au cours de laquelle l'OMS a choisi de supprimer Congenital Lyme en tant que code ICD11. Nous demandons la transparence et un processus équitable, et demandons que le scientifique en chef de l'OMS, le Dr Soumya Swaminathan, dont nous comprenons que la position inclut la science, la recherche et les preuves dans l'élaboration des politiques, soit appelé à examiner à la fois le processus et la science.
Nous demandons immédiatement le retour de la « borréliose congénitale de Lyme » en tant que catégorie « autonome » dans les nouveaux codes CIM-11. Ce n'est qu'avec une telle classification que nous pouvons vraiment cataloguer l'étendue de la maladie causée par la maladie de Lyme (et d'autres co-infections) pendant la grossesse et leurs effets sur l'enfant à naître. Nous avons besoin d'études prospectives sur les femmes enceintes et d'un suivi longitudinal des enfants nés de ces mères. De meilleures ressources scientifiques et financières permettront de mieux comprendre ce processus pathologique. Nous demandons que la science et la transparence du processus prévalent dans la lutte contre la «maladie de Lyme congénitale».

Merci d'avoir pris en compte notre point de vue. Nous attendons avec impatience de vos nouvelles et anticipons une réponse favorable de l'OMS pour soutenir nos efforts visant à accroître la visibilité des mères et des bébés vivant avec la maladie de Lyme.

Cordialement,

Dr. John S. Lambert, MD, PhD
Professeur de médecine et de maladies infectieuses
Mater Misericordiae Hospital et UCD School of Medicine
Dublin
Irlande

Pr Christian Perronne, MD, PhD
Professeur de Maladies Infectieuses et Tropicales
Faculté de Médecine Paris-Ile de France-Ouest
Université de Versailles-St Quentin en Yvelines (UVSQ)
Paris-Saclay
France

cc. Dr Soumya Swaminathan, scientifique en chef de l'OMS.

Le site web Vis-à-Vis Symposium

John Lambert en est l'administrateur principal (pour la médecine).

Le symposium Vis-à-Vis du 7 juin 2014 à Londres

Les orateurs étaient:

• The Countess of Mar
  Margaret of Mar is the 31st Countess of Mar, our oldest peerage, and has been a member of the House of Lords since 1975. When the House of Lords act was passed in 1999 to restrict the number of hereditary peers Lady Mar was elected to the new House receiving the highest number of votes in support. [...]
• Dr Bernard Raxlen, USA
  Psychiatry, Psychoneuroimmunology and Tick-Borne Disease.
  “Welcome and a warm thank you to our British Medical colleagues. It is a reaching out across the ocean. A dialogue between medical colleagues, with the intention of sharing ideas and clinical strategies pertaining to the diagnosis and treatment of Tick Borne Diseases (Borrelia), its subspecies and co-infections”.
• Dr Leo Shea, USA
  Neuropsychiatrist and Professor of Rehabilitation Medicine.
  Neuropsychiatric and neurocognitive abnormalities in the frontal and prefrontal cortex as related to executive functioning, psychiatric illness in cases of disabling Lyme encephalopathy.
• Dr Daniel Cameron USA
  Epidemiology/Research:
  The evolution of the revised treatment guidelines for ILADS, built on scientific, evidence- based medicine published studies. A critique of IDSA guidelines and their refusal to review the literature of persisting relapsing Lyme Disease.The serious implications and far- reaching consequences for the health care industry and the consequences of those insured.
• Dr Joseph Jemsek USA
  FCAP is board certified in Infectious Diseases.
  Denial of plague. A comparison of Lyme to AIDS. Commonalities and differences. Attempt at the unification of the microbiology, pathophysiology, diagnosis and treatment of”persistent multimicrobial synergistic infection” (PMSI).
• Dr Alan MacDonald USA
  Pathologist
  Borreliosis from a pathologists perspective. The ubiquitous nature of Borreliosis as found and demonstrated in 125 autopsies, with no organ system spared.
• Dr Elizabeth Valentine-Thon USA.
  Health Diagnostics and Research Institute, New Jersey.
  Immunology, virology, molecular biology and Infectious disease diagnostics.
  Critical errors in the present day accepted laboratory diagnosis of Borreliosis. Dangers of the two tier system (ELISA WESTERN BLOT). New avenues for more accurate and valid diagnostic options such as the ITT and new blood cultures techniques, as well as other new testing procedures.
• Dr Steven Bock
  30 years practicing complementary and progressive medicine. A clinical instructor of Family Medicine at Albany Medical College (USA) and the New York Medical College.
  Functional medicine in the service of the diagnosis and treatment of Tick-Borne diseases, with emphasis on immune support, GI health, detoxification, heavy metal reduction, herbal medicine and alternative therapies including ondamed, acupuncture, IV nutritional therapy and other important supportive modalities.

Participation de John S. Lambert à la conférence ILADSEUROPE2017 co-organisée par Christian Perronne à Paris

Cette conférence a eu lieu les vendredi 17 et samedi 18 mars 2017.
John S. Lambert a fait une conférence le 17 mars de 8h45 à 9h25 : Conférence scientifique (salle Vendôme): Lyme et co-infections : l'expérience irlandaise
Puis, il a animé un groupe de 13h30 à 14h00 (salle Vendôme) : Sélection de résumés oraux.

La 1st European Crypto-Infections Conference 2019

La première conférence européenne sur les crypto-infections s'est tenue à Dublin du vendredi 31 mai au samedi 1er juin. Elle s'est penchée sur les aspects scientifiques de la maladie de Lyme et des co-infections. Il s'agissait d'une conférence scientifique fondamentale destinée aux chercheurs universitaires et aux groupes de patients, ainsi qu'aux médecins et aux vétérinaires.

Dans ce document, on trouve le programme (qui est aussi proposé en pdf):

Le vendredi 31 mai 2019:

• 13:10 Cryptic Infections in Pregnancy Prof. John (Jack) Lambert
• 13:40 The Value and Limitations of Serological Assays for the Diagnosis of Crypto-Infections, including Tick-Borne Infections Michael Cook
• 14:20 Tick-borne Disease Diagnostics: The Good the Bad and the Ugly Dr. Leona Gilbert
• 15:00 Molecular biology and ecology of ticks and tick-borne pathogens: co-existence, distribution, interactions Dr. Natasha Rudenko
• 16:15 Antigen Based Diagnostics: the value of PCR in crypto-infection diagnosis Prof. Christian Perronne
• 17:15 Patient care in Québec and recent initiatives in Canada Dr. Amir Khadir
  
  

Le samedi 1er juin 2019:

• 08:15 Developing Effective Treatment of Persistent Lyme Disease: Where are we now? Dr. Ying Zhang [Présentation de Ying Zhang sur le site de la LDA (Lyme Disease Association), une des deux organisations militantes les plus actives parmi les patients de Lyme et prônant les recommandations de l'ILADS contraires au consensus mondial]
• 08:40 Two double blind randomized trials in Congo-Kinshasa to evaluate the efficacy of Artemisia tea versus chemical recommended drugs to treat malaria and schistosomiasis. Results and financial issues Dr. Lucile Cornet-Vernet
• 09:25 Chronic infection in Alzheimer’s disease, Lyme disease and type 2 diabetes Dr. Judith Miklossy
• 10:30 Bartonella (and other zoonotic diseases) and its role in Chronic Infection, evidence of persistence and challenges of treatment Dr. Ricardo G. Maggi
• 11:25 The role of international advocacy in supporting patients’rights to care Jenna Luché-Thayer
• 11:45 Patient groups: how to advocate for recognition and treatment of Tick-Borne Infections (lessons learned from HIV, and current status with Lyme disease) Fred Verdult
• 13:15 Biofilms: in vitro and in vivo evidence of crypto-infections and challenges with Borrelia infection Prof. Niels Hoiby
• 14:00 Bacteriophages as diagnostic markers and therapeutic agents for predicting and treating Lyme disease Dr. Jinyu Shan
• 14:45 Submitted Abstract: Metagenomic 16S rRNA gene sequencing survey of Borrelia species in Irish samples of Ixodes ricinus ticks Ross Murtagh
• 15:00 Submitted Abstract: Molecular Detection of Borrelia in Human Tissue Two case * studies Vett Lloyd [Une canadienne à laquelle Christian Perronne est allé porter son soutien...]
• 15:15 Submitted Abstract: Isolation of live and cultivable Borrelia from patients after extended antibiotic treatments Marina Golovchenko, Natasha Rundenko
• 15:30 Conclusions: What are next steps to advance our understanding of these Crypto- infections and support patients with these ‘undiagnosed’ illnesses? Prof. Christian Perronne, Prof. John (Jack) Lambert

Suivent les biographies des orateurs.

Et enfin divers logos: OSCR Charity Logo, LRC (Lyme Resource Centre, un Charity écossais) Tron House (c'est le site qui héberge de OSCR Charity Logo).

La 2d European Crypto-Infections Conference 2020

La 2ème conférence européenne sur les crypo-infections s'est tenue à Dublin le samedi 26 septembre et le dimanche 27 septembre 2020. Le thème semble avoir été "Maladie de Lyme & autres infections cachées".

DAY 1- THE SCIENCE
CHAIRS –Prof John (Jack) Lambert & Christian Perronne

• 13:00 Introduction Prof John (Jack) Lambert
• 13:10 One Health: Forming Collaborations that transcend disciplinary boundaries Dr Cheryl Stroud
• 13:40 PCR for crypto-infections diagnosis in patients with PTLDS :Comparison of matrices (venous blood, capillary blood, urine and saliva) Prof Christian Perronne
• 14:20 Clinical spectrum of persistent Bartonella infection and important considerations in Diagnosis and Treatment Dr B Robert Mozayeni
• 15:20 Hiding in the body: metamorphoses of Lyme disease spirochetes Dr. Natasha Rudenko
• 15:50 Coffee break
• 16:15 Late Lyme carditis- Samantha Bishop, Hasibul Haque, Vett Lloyd
  Tissue distribution of B. burgdorferi and B. miyamotoi in wildlife - Chris Zinck and Vett Lloyd
  Borrelia bissettii in Canada - Samantha Bishop and Dr Vett Lloyd
• 17:15 Uptake and intracellular processing of borreliae by human macrophages Prof Stefan Linder
• 18:15 End of Conference first day

DAY 2 From Bench to Bedside (De la paillasse au chevet du patient).

• 8:00 Introduction -CHAIRS Prof Christian Perronne & Fred Verdult
• 8:15 Pioneering Dutch Lyme Patients, Inspired By The AIDS Movement: The United Strategic Path From NO HEALTH To ONE HEALTH - Fred Verdult
• 9:00 How to make a disease disappear. Michael Cook
• 9:10 PCR for crypto-infections diagnosis in patients with PTLDS : Correlation with clinical signs - Dr Christian Perronne
• 9:50 Coffee break
• 10:20 Lyme Triad- A Research Study To Advance Our Knowledge Of Treatment Of Tick-Borne Infections- Dr Jack Lambert
• 10:40 Assessing the tick infection prevalence in an emerging region for Lyme disease- Julie Lewis (Accepted abstract)
• 11.05 Babesiosis- a one health approach Dr Willie Weir

11.30 'Chronic Lyme Disease': a model for persistent pathogen involvement in chronic disease: an expression of interest application to the MRC- Dr Karl Morten

• 12:15 Lunch
• 13:15 Three presentations (submitted abstracts) of 15 minutes
• 1- Unravelling Some of the Complexities of Laboratory Testing in Lyme disease and Other Infections- Dr Armin Schwarzbach
  2- Neglected Infections And Gastrointestinal Issues In Patients With Late / Persistent / Chronic Vector-Borne Infections- Tanja Mijatovic
  3- Specific Borrelia phages as new strategies for diagnostics Louis Teulieres
• 14:00 Lyme Disease: Columbia research, treatment trials, and future directions- Dr Brian Fallon
• 14:45 Ticks bite in pregnancy- How are the offspring affected: lessons from animal models, application to humans. Prof John (Jack) Lambert
• 15:30 Endocarditis, a common pathology caused by chronic Bartonella infections in both animals and humans-Dr Bruno Chomel
• 16.15 Conclusions: Prof Christian Perronne & Prof John Lambert
• 16:30 End of conference

SPEAKERS’ BIOGRAPHIES

Prof Jack (John) Lambert

Consultant Infectious Diseases, Mater Misericordiae University Hospital/ University College Dublin, Ireland.

Dr John lambert is is a consultant in Infectious diseases and genitourinary medicine, and has been practicing in Dublin Ireland as a consultant in the Mater and Rotunda Maternity hospitals, with teaching appointment at UCD School of Medicine and Medical Science. He is director of the National Isolation Unit for Highly Infectious Diseases at the Mater Misericordiae University Hospital and a member of the National Viral Hemorrhagic Fever Committee of the HSE. He has also been involved in the Sexual Health Strategy group in Ireland and teaching GP in Ireland on the subject of STDs. He has presented widely in the field of Lyme and co infections in the last 3 years through EU and USA conferences supported by the International Lyme and Associated Diseases Society (ILADS).

Dr. Brian Fallon Director

Director, Lyme and Tick-borne Diseases Research Center, Columbia University Irving Medical Center, New York, USA

Dr. Brian Fallon (MD, MPH) trained in epidemiology and psychiatry at Columbia University, where he developed an expertise in clinical trials research. His work on Lyme disease began in 1991 and has included studies in children and adults, focusing on phenomenology, diagnostics, neuroimaging, neurocognition, and treatment studies. He has lectured widely and published extensively, including a recent book entitled Conquering Lyme Disease: Science Bridges the Great Divide (Columbia University Press, 2018). He has received federal and foundation grants and currently serves on the Department of Health and Human Services Tick-borne Disease Working Group. Current research projects at the Columbia Lyme Center include: a) two treatment studies (e.g., disulfiram; meditation); b) a national cohort study in Denmark to clarify whether Lyme disease is associated with psychiatric manifestations; c) precision medicine collaborations using the Center’s biorepository of specimens from longitudinal and cross sectional studies; d) post-mortem brain studies; e) a collaborative Powassan Virus diagnostic and treatment development study; f) a biometric studies to develop a new measure of symptom burden.

Dr B Robert Mozayeni

Expert in Translational Medicine, the science and art of advancing medical science safely and efficiently

Dr. Mozayeni trained in Internal Medicine, Rheumatology and Molecular Biophysics in a physician-scientist research residency at Yale-New Haven Hospital, where Lyme disease was discovered and treated by Rheumatologists in the Rheumatology section. He subsequently became a Senior Staff Fellow at the National Institutes of Health (NIH) where he completed a second fellowship in Rheumatology. Since 1994, while in private practice, has held clinical privileges at Suburban Hospital, a member of Johns Hopkins Medicine and an affiliate of the NIH Clinical Center.
Recently, he became the President of ILADS. His main objective with ILADS is the same as with his professional career – to advance the science of translational medicine and learn from the issues presented by Lyme disease, how to more rapidly advance medical science. His career passion is to find the fastest path for advancing medical science in diverse areas of patient need and controversy to validate and continuously improve best clinical practices.
He is the Chief Medical Officer of Galaxy Diagnostics, LLC. Recently, he founded ‘T Lab’ focusing on the use of high resolution microscopy to identify cryptic infections and demonstrate how they cause disease. He is a Fellow of the non-profit Think Lead Innovate Foundation and he is a founder of the non-profit Foundation for the Study of Inflammatory Diseases.
His work on cerebrovascular diseases, as a Rheumatologist, he began to appreciate the importance of Bartonella cryptic infections. Over the past 12 years, he has been actively researching chronic rheumatic and cerebrovascular diseases and their relationship to persistent human Bartonella infection.

Dr. Natasha Rudenko, PhD.

Deputy Head of the laboratory of Molecular Ecology of Vectors and Pathogens at the Institute of Parasitology of Biology Centre Academy of Sciences of the Czech Republic

For the last two decades her research were focused on ecology, epidemiology, and distribution of arthropod-borne diseases and vector-host-pathogen interactions. The main interests are: ecology, epidemiology, genetic diversity of the causative agent of human Lyme disease, the spirochetes from Borrelia burgdorferi sensu lato complex, in Europe and around the world and their impact in global public health, microbial infectivity, pathogenicity, survival behaviors, and response to antibiotic treatment or capability to transform into persisting forms that cause relapsing or chronic diseases.

Prof Christian Perronne

Professor of Infectious and Tropical Diseases at the University of Versailles-St Quentin (UVSQ), France

Christian Perronne, MD, PhD, qualified in Internal medicine, is Professor of Infectious and Tropical Diseases at the University of Versailles-St Quentin (UVSQ), Paris-Saclay, France. Since 1994, he is chief of a Department of Medicine at the Raymond Poincaré University Hospital in Garches, Greater Paris University Hospitals group. He had major responsibilities within several institutions: Pasteur institute in Paris (vice-director of the national tuberculosis reference center), French College of Professors of Infectious and Tropical Diseases (chairman), French National Technical Advisory Group of Experts on Immunisation (chairman), French Drug Agency (chairman of several working groups making evidence based recommendations), Superior Council for Public Hygiene of France (Chairman), French High Council for Public Health (Chairman of the Communicable diseases commission), INSERM, National Council of Universities (Chairman for infectious and tropical diseases), European Advisory Group of Experts on Immunisation at the World Health Organization (vice-chairman). He was principal investigator of several major clinical trials. He is author or co-author of more than 300 scientific publications in peer-reviewed journals. Since 1994, Christian Perronne is involved in the management of chronic Lyme and associated diseases. He is leading a coalition of patients and physicians for the recognition of chronic Lyme disease and other crypto-infections (hidden infections) in France. He is cofounder and vice-president of the French federation against tick-borne diseases (FFMVT) and president of its scientific council. He is author of a book “La vérité sur la maladie de Lyme” (in French) (“The truth about Lyme disease”), Odile Jacob publisher, Paris, which will be published in English in May 2020 (“Crypto-infection, the truth about Lyme disease and other hidden infections”), Hammersmith publisher, London, Dublin.

Dr Alain Trautmann

Emeritus researcher, Cochin Institute, Paris, France

Alain Trautmann is an emeritus researcher form CNRS. He has been working first in neurobiology, then in immunology. Still active in cancer immunotherapy at the Cochin Institute in Paris, he became interested in Lyme disease for family reasons a few years ago. He is member of the scientific advisory board of FFMVT, the French federation of tick-borne diseases

Dr Hugues Gascan

Research Director at CNRS (French National Centre for Scientific Research), IGDR, Rennes and Angers, France

Hugues Gascan is a research director from CNRS, the French National Centre for Scientific Research, and he has been working in the field of immunology, and more particularly in cytokines and chronic diseases for approximately 35 years. He has been interested in Lyme disease for few years now, leading a project whose aim is an analysis of the immune response in late and chronic forms of this pathology, in order to facilitate its diagnosis.

Stefan Linder

Professor for Cellular Microbiology, University Medical Center Eppendorf, 20246 Hamburg, Germany

Stefan Linder holds a professorship for Cellular Microbiology at the University of Hamburg since 2009. His research is focused on the interaction between bacterial pathogens and human immune cells, and specifically on the uptake and intracellular processing of Borrelia burgdorferi by primary human macrophages. His group is particularly interested in the regulation of cytoskeletal dynamics and intracellular trafficking pathways that contribute to phagocytosis and phagolysosomal degradation of borreliae.

Dr Cheryl Stroud, DVM, PhD

One Health Commission, USA

Dr. Stroud has enjoyed professional experiences in Industry, Academic Research / Teaching, Private Veterinary Practice and as a One Health practitioner. After years of research she returned to small animal veterinary practice where she enjoyed teaching clients about Vector-Borne and Zoonotic Diseases. In 2010 she was instrumental in creating the North Carolina One Health Collaborative, Chairing its Steering Committee for over three years and facilitating collaborative formation of an interinstitutional One Health course, One Health: Philosophy to Practical Integration of Human, Animal and Environmental Health, cross-listed at Duke, UNC and NC State. In 2013 she served on a US National Biodefense Science Board working group on Situational Awareness, Strategic Implementation and Bio-Surveillance.

Currently as Executive Director of the One Health Commission Dr. Stroud’s primary focus is educating, locally, nationally and globally, about the need for One Health when addressing issues like vector-borne diseases. She shares updates about the global One Health movement with audiences around the world and seeks to connect One Health stakeholders into Action Teams, strategic networks and partnerships that educate about the full scope of and critical need for One Health thinking and acting at all levels of academia, research, clinical practice and government. She refers to One Health as our ‘Ray of Hope for the Future’.

Dr Vett Lloyd

Professor of Biology – Mount Allison University, Canada

Dr. Vett Lloyd is a professor of Biology at Mount Allison University with expertise in molecular genetics and epigenetics. Her research has included finding animal models for rare human genetic diseases, cloning organisms and cancer cell biology. For the past decade her lab has been working on the genetics of ticks and the pathogens they transmit. Dr. Lloyd is the founding member of the Maritime Lyme Disease Network and Canadian Lyme Consortium, an interdisciplinary network of researchers tackling the biological, social and human dimensions of Lyme disease and incorporating the Lyme patient community as full partners in this endeavor. Dr. Lloyd runs the Mount Allison tick lab, which does tick research that provides tick identification and pathogen testing to members of the public and veterinary medical community in the Maritimes. Her published work in this area includes tick genetics, tick behaviour and the use of dogs as a sentinel species to predict the risk of Lyme disease in humans. Additionally, she has a special interest in encouraging citizen science in tick surveillance activities as a way to promote tick education to communities.

Dr Karl Morten

Principal Investigator and Director of Graduate Studies in the Nuffield Department of Women’s and Reproductive Health.

The Morten lab has a long standing interest in understanding the role of mitochondria in health and disease and have built up over the last 10 years technologies allowing this to be studied in a high throughput format. As the leading group in Oxford working on mitochondria the group collaborate widely in Oxford, leading to numerous publications in this area. Recently we have been actively exploring the mechanisms behind Myalgic Encephalomyelitis/Chronic fatigue syndrome (ME/CFS) (https://www.mortengroup.org.uk/) in addition to developing new approaches to study cancer energetics in a project funded by Horizon 2020.

Dr Bruno B. Chomel (DVM, MS, PhD, Dr. Sc)

Dr. Chomel graduated from the School of Veterinary Medicine in Lyon, France in 1977 and received his DVM degree in 1978 from the University of Lyon, France. He was a faculty member of the Lyon Veterinary School from 1979 until 1990. Dr. Chomel received a MS in Microbiology (Pasteur Institute, Paris, 1981), a MS in Immunology (University of Lyon, 1982) and his PhD in Microbiology (1984), as well as his research directorship degree (former Dr.Sc degree) in 1989 from the same University. He served for 2 years as an Epidemic Intelligence Service Officer for the Centers for Disease control in Atlanta. Dr. Chomel served as a consultant in several international organizations including the French Ministry of Foreign Affairs, the United Nations Development Program, the World Health Organization, the World Bank, and NGOs such as Bioforce and Vétérinaires sans Frontières. Dr. Chomel joined the faculty of the School of Veterinary Medicine, UC Davis in 1990 where he is Professor of Zoonoses since 1999 and was nominated distinguished Professor in 2018. His research centers on cat scratch disease and Bartonella infections in domestic animals and wildlife, the epidemiology of rabies and plague and zoonoses of wildlife. He has authored or co-authored more than 220 peer-reviewed publications and numerous book chapters. He was the Director of the World Health Organization/Pan American Health Organization (WHO/PAHO) Collaborating Center on New and Emerging Zoonoses from 1997 until 2009 and was the Director of the Master of Preventive Veterinary Medicine at UC-Davis from 1998 until 2001 and from 2008 until 2013. Dr. Chomel was elected corresponding member of the French National Academy of Medicine in January 2007.

Fred Verdult

Chairman of the Dutch Lyme Patients Association

In 2018, Fred Verdult received the royal decoration as Knight for his 20 years of commitment to people living with HIV, and in particular for bringing the patient perspective into research on HIV cure. Since 2018 he is chairman of the Dutch Lyme Patients Association, as well as founding father of the Dutch Lyme Fund (Lymefonds). ‘Partly due to the efforts of activists, I now only take one HIV pill per day, and I have never been ill because of HIV at all. The contrast with Lyme couldn’t be greater: my struggle to obtain a diagnosis, the disabling symptoms and my 78 daily pills and drinks.’

Dr Willie Weir

Senior University Clinician (Veterinary Pathology, Public Health & Disease Investigation)Associate (Institute of Biodiversity Animal Health & Comparative Medicine), University of Glasgow, UK

Dr Weir graduated from the University of Glasgow Veterinary School in 1995. After spending five years in mixed practice in the North of England, he returned to Glasgow on a Wellcome Trust Fellowship to study the molecular epidemiology of Cryptosporidium. Following a secondment to the State Veterinary Service to assist with the Foot and Mouth crisis in 2001, Dr Weir accepted a Scholarship from Glasgow Veterinary School to allow him to pursue a PhD in Molecular Parasitology, which he completed in 2006. His research interests have developed in a number of areas including the genetics, genomics and transcriptomics of protozoan parasites, principally Theileria and Babesia. He is Principal Investigator on several projects investigating tick-borne pathogens and is currently funded to pursue research by the Scottish Government, EU, HBLB and the Donkey Sanctuary. In 2016, Dr Weir was appointed as Academic Head of the Veterinary Diagnostic Service Infectious Disease Unit at the University of Glasgow.

Michael J Cook

BSc degree from London University (Physics and Mathematics). His 36 year career included computer chip design, research and development and process engineering in the semiconductor industry. Working in the United Kingdom, United States and leading multinational teams from the US, Europe and Asia. He was diagnosed with Lyme disease in 2009 and started to investigate Lyme and associated diseases. He is author or co-author of 6 papers on Lyme disease and has presented his work at conferences in Paris, Boston, Dublin and London. Other work includes presentations to members of the UK Houses of Lords and Commons, medical and national & local government environmental and health agencies. He also investigated a UK Lyme testing laboratory and provided the evidence of failures in support of patient representations to the UK Parliamentary and Health Services Ombudsman. He also accompanied a team to the United Nations where evidence of regarding human rights abuses related to patients and doctors treating Lyme disease was presented.

cet article est une ébauche